Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yexiang Lin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Iscience|May 28, 2026
Fabrication of RADA32/Ngf_EE/MSCs composite hydrogel and its protective mechanism against radiation-induced ototoxicityYuqing Bao, Yexiang Lin, Yang Shen, et al.
Current Pharmaceutical Design|October 30, 2020
DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNAChengyu Hu, Kai Liu, Bei Wang, et al.
Current Pharmaceutical Design|October 30, 2020
The Function of LncRNA FTX in Several Common CancersYexiang Lin, Yujie Shen, Jinlan Chen, et al.
Current Pharmaceutical Design|July 6, 2021
The Role of Tumor-related LncRNA PART1 in CancerJinlan Chen, Enqing Meng, Yexiang Lin, et al.
Current Pharmaceutical Design|December 3, 2020
XIST: A Meaningful Long Noncoding RNA in NSCLC ProcessYujie Shen, Yexiang Lin, Kai Liu, et al.
Frontiers in Cardiovascular Medicine|January 30, 2023
Multiple-model machine learning identifies potential functional genes in dilated cardiomyopathyLin Zhang, Yexiang Lin, Kaiyue Wang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Iscience|May 28, 2026
Fabrication of RADA32/Ngf_EE/MSCs composite hydrogel and its protective mechanism against radiation-induced ototoxicityYuqing Bao, Yexiang Lin, Yang Shen, et al.
Current Pharmaceutical Design|October 30, 2020
DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNAChengyu Hu, Kai Liu, Bei Wang, et al.
Current Pharmaceutical Design|October 30, 2020
The Function of LncRNA FTX in Several Common CancersYexiang Lin, Yujie Shen, Jinlan Chen, et al.
Current Pharmaceutical Design|July 6, 2021
The Role of Tumor-related LncRNA PART1 in CancerJinlan Chen, Enqing Meng, Yexiang Lin, et al.
Current Pharmaceutical Design|December 3, 2020
XIST: A Meaningful Long Noncoding RNA in NSCLC ProcessYujie Shen, Yexiang Lin, Kai Liu, et al.
Frontiers in Cardiovascular Medicine|January 30, 2023
Multiple-model machine learning identifies potential functional genes in dilated cardiomyopathyLin Zhang, Yexiang Lin, Kaiyue Wang, et al.
Pageof 1